Showing results (3151-3160 of 13,858) with videos related to

Sort By:
Pageof 1,386
American Heart Journal|March 1, 1991
Acute hemodynamic effects of intravenous diperdipine, a new dihydropyridine derivative, in coronary heart diseaseM Di Donato, M Maioli, F Venturi, et al.
American Heart Journal|May 15, 2018
Risk of cardiovascular events and incident atrial fibrillation in patients without prior atrial fibrillation: Implications for expanding the indications for anticoagulationXiaoxi Yao, Bernard J Gersh, Lindsey R Sangaralingham, et al.
American Heart Journal|May 15, 2018
Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgeryAlice Wang, Angie Wu, Daniel Wojdyla, et al.
American Heart Journal|May 15, 2018
Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shockSteven Hsu, Swetha Kambhampati Thiruvengadam, Christopher M Sciortino, et al.
American Heart Journal|May 15, 2018
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and DesignDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
American Heart Journal|May 15, 2018
Investigation of Motivational Interviewing and Prevention Consults to Achieve Cardiovascular Targets (IMPACT) trialEugenia Gianos, Antoinette Schoenthaler, Yu Guo, et al.
American Heart Journal|May 15, 2018
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)Warren H Capell, Marc P Bonaca, Mark R Nehler, et al.
American Heart Journal|May 15, 2018
Trends and outcomes of cardiac transplantation from donors dying of drug intoxicationHaider J Warraich, Di Lu, Stacy Cobb, et al.
American Heart Journal|May 15, 2018
Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trialAndrew P Ambrosy, Ankeet S Bhatt, Amanda L Stebbins, et al.
American Heart Journal|May 16, 2018
Design of a Phase 3 trial of intracoronary administration of human adenovirus 5 encoding human adenylyl cyclase type 6 (RT-100) gene transfer in patients with heart failure with reduced left ventricular ejection fraction: The FLOURISH Clinical TrialWilliam F Penny, Timothy D Henry, Matthew W Watkins, et al.
Pageof 1,386